Two studies of children with HIV presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) in Kigali, Rwanda showed that even if they are on antiretroviral therapy (ART) and have fully suppressed viral loads, they carry markers of chronic immune activation that could lead to premature cardiovascular disease and other non-AIDS-defining conditions.
One of the studies linked this to the amount of intact proviral DNA they carry in their ‘reservoir’ cells; as other studies have previously shown, this was significantly lower in children who received ART shortly after birth.
Read the full news story at aidsmap.
All aidsmap reports from IAS 2025 can be accessed here.
Source : aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.